Spruce Biosciences, Inc. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
Spruce Biosciences, Inc. (SPRB) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $3.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2026-08-12
- Spruce Biosciences, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2026-06-30 was $0.00.
- Spruce Biosciences, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2026-03-31 was $3.72M.
- Spruce Biosciences, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2025-06-30 was $0.00.
- Spruce Biosciences, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2025-03-31 was $0.00.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $3.72M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $3.72M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |